Official registry · BMU
Bangladesh Medical UniversityBMU CTR

The Registry Office does not review or approve the safety and science of the studies listed on this website.

Read our full disclaimer for details.

Tuberculosis Treatment Adherence Using Digital Reminders

BDCTR ID
BDCTR-2026-000085
Sponsor
Bangladesh Medical University
Information provided by
Dr Afroza Sultana (Responsible Party)
Last Update Posted
2026-07-28

Completed

No longer looking for participants

Trial Contacts

ContactsICMJE

Contact information is displayed when a study is open for participants to join.

Study Record Dates

First SubmittedICMJENot provided
First PostedICMJE

2025-08-28

Results First PostedICMJE

2026-07-28

Last Update Posted

2026-07-28

Last Verified*

2026-07

Outcome Measures

Primary Outcome Measures*ICMJE

Treatment completion rate [Time Frame: End of therapy, up to 6 months]

Secondary Outcome Measures[*]ICMJE

Loss to follow-up [Time Frame: Up to 6 months]

Other Pre-specified Outcome MeasuresNot provided

See all versions of this study

Trial Description

Brief Title*ICMJE

Tuberculosis Treatment Adherence Using Digital Reminders

Official Title*§ICMJE

Digital Adherence Technology With SMS Reminders Versus Directly Observed Therapy for Tuberculosis Treatment Completion

Acronym[*]

TB-DIGITAL

Brief Summary*

This trial compared digital adherence technology with SMS reminders against standard directly observed therapy on tuberculosis treatment completion.

Detailed Description

Adults starting tuberculosis treatment were randomised to digital adherence technology with SMS reminders or directly observed therapy. Treatment completion was the primary endpoint.

Study Type*ICMJE

Interventional

Study Phase*ICMJENot provided
Study Design*§ICMJE

Allocation: Randomized

Interventional Model: Parallel Assignment

Masking: None (Open Label)

Primary Purpose: Treatment

Condition*ICMJE

Tuberculosis

Keywords

tuberculosis

adherence

digital health

SMS

Intervention*ICMJE

Behavioral: Digital adherence technology with SMS — Medication sleeves with daily SMS reminders.

Study Arms*ICMJE

Experimental: Digital adherence

Interventions: Behavioral: Digital adherence technology with SMS

Active Comparator: Directly observed therapy

PublicationsNot provided

Recruitment Information

Recruitment Status*ICMJE

Completed

Enrollment (Anticipated)*§ICMJE

740

Study Start Date*§ICMJE

2025-09-01

Primary Completion Date*

2026-05-31 (Final data collection date for primary outcome measure)

Study Completion Date*§ICMJE

2026-06-30

Eligibility Criteria*ICMJE

<p>Inclusion Criteria:</p><ul><li>Adults starting first-line tuberculosis treatment.</li><li>Access to a mobile phone.</li></ul><p>Exclusion Criteria:</p><ul><li>Drug-resistant tuberculosis.</li></ul>

Sex/Gender*ICMJE

Sexes Eligible for Study: All

Ages*ICMJE

18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers*§ICMJE

No

Location CountriesICMJE

Bangladesh

Administrative Information

BDCTR NumberICMJE

BDCTR-2026-000085

Other Study ID Numbers[*]ICMJE

BMU-MED-2026-005

Has Data Monitoring Committee

Yes

Studies a U.S. FDA-regulated Drug ProductNot provided
Studies a U.S. FDA-regulated Device ProductNot provided
Device Product Not Approved or Cleared by U.S. FDANot provided
Pediatric Postmarket Surveillance of a Device ProductNot provided
Product Manufactured in and Exported from the U.S.Not provided
IPD Sharing StatementICMJE

Plan to Share IPD: Not provided

Current Responsible Party*

Dr Afroza Sultana

Current Study Sponsor*ICMJE

Bangladesh Medical University

CollaboratorsICMJE

National Tuberculosis Control Programme

InvestigatorsICMJENot provided
Registry Account

Imported legacy public registry

Symbol Legend

*
Required
*§
Required if Study Start Date is on or after January 18, 2017 — required for every BMU study
[*]
Conditionally required
No Symbol
Unmarked fields are optional. If no information is provided, fields will be labeled as “Not provided”.
ICMJE
Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP